"10.1371_journal.pone.0112735","plos one","2014-11-12T00:00:00Z","Angel Soto-Hermida; Mercedes Fernández-Moreno; Natividad Oreiro; Carlos Fernández-López; Sonia Pértega; Estefania Cortés-Pereira; Ignacio Rego-Pérez; Francisco J Blanco","Grupo de Genómica, Servicio de Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A Coruña, España; Unidad de Epidemiología. Instituto de Investigacion Biomedica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A Coruña, España","Conceived and designed the experiments: IRP FJB. Performed the experiments: ASH MFM ECP NO CFL. Analyzed the data: IRP FJB SP. Contributed reagents/materials/analysis tools: ASH MFM NO CFL ECP. Wrote the paper: IRP FJB.","The authors have the following interests. The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","11","Angel Soto-Hermida","ASH",8,TRUE,2,5,3,2,TRUE,FALSE,FALSE,0,NA,FALSE
